Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cocrystal Pharma Inc (COCP)
NASDAQ:COCP
Cocrystal Pharma (COCP) Stock Price & Analysis
984 Followers
COCP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.33 - $3.29
Previous Close$2.26
Volume28.39K
Average Volume (3M)33.42K
Market Cap
$22.99M
Enterprise Value-$1.51M
Total Cash (Recent Filing)$26.35M
Total Debt (Recent Filing)$1.85M
Price to Earnings (P/E)―
Beta1.38
Next Earnings
Aug 12, 2024EPS Estimate
-$0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.65
Shares Outstanding10,173,790
10 Day Avg. Volume39,788
30 Day Avg. Volume33,419
Standard Deviation0.34
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.88
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.14
Forecast
1Y Price Target
$10.00Price Target Upside325.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Cocrystal Pharma News
Bulls Say, Bears Say
Bulls Say
Clinical DataCC-42344 showed antiviral activity against various influenza A strains with favorable pharmacokinetic and safety profiles.
Financial PerformanceFinancial results reported a net loss substantially narrower than forecast due to lower than projected operating expenses.
Market OpportunityMassive market opportunity remains in treating influenza.
Bears Say
Clinical Testing RisksFailure to advance CC-31244 through clinical testing.
Financial PerformanceCocrystal Pharma reported a full-year 2023 net loss of $1.86 per share.
Partnership RisksInability to identify a partner for CC-31244.
---
Ownership Overview
88.80%
Insiders
3.32% Mutual Funds
2.68% Other Institutional Investors
5.19% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
COCP FAQ
What was Cocrystal Pharma Inc’s price range in the past 12 months?
Cocrystal Pharma Inc lowest stock price was $1.32 and its highest was $3.29 in the past 12 months.
What is Cocrystal Pharma Inc’s market cap?
Currently, no data Available
When is Cocrystal Pharma Inc’s upcoming earnings report date?
Cocrystal Pharma Inc’s upcoming earnings report date is Aug 12, 2024 which is in 24 days.
How were Cocrystal Pharma Inc’s earnings last quarter?
Cocrystal Pharma Inc released its earnings results on May 13, 2024. The company reported -$0.39 earnings per share for the quarter, beating the consensus estimate of -$0.54 by $0.15.
Is Cocrystal Pharma Inc overvalued?
According to Wall Street analysts Cocrystal Pharma Inc’s price is currently Undervalued.
Does Cocrystal Pharma Inc pay dividends?
Cocrystal Pharma Inc does not currently pay dividends.
What is Cocrystal Pharma Inc’s EPS estimate?
Cocrystal Pharma Inc’s EPS estimate is -$0.48.
How many shares outstanding does Cocrystal Pharma Inc have?
Cocrystal Pharma Inc has 10,173,790 shares outstanding.
What happened to Cocrystal Pharma Inc’s price movement after its last earnings report?
Cocrystal Pharma Inc reported an EPS of -$0.39 in its last earnings report, beating expectations of -$0.54. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cocrystal Pharma Inc?
Currently, no hedge funds are holding shares in COCP
---
Cocrystal Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (325.53% Upside)
$10.00 (325.53% Upside)
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.07%
12-Months-Change
Fundamentals
Return on Equity
-58.51%
Trailing 12-Months
Asset Growth
-29.85%
Trailing 12-Months
Company Description
Cocrystal Pharma Inc
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.
---
COCP Stock 12 Month Forecast
Average Price Target
$10.00
▲(325.53% Upside)
Technical Analysis
Best Analysts Covering COCP
1 Year
1 Year Success Rate
1/17 ratings generated profit
1 Year Average Return
-42.05%
reiterated a buy rating 28 days ago
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 5.88% of your transactions generating a profit, with an average return of -42.05% per trade.
---